EUVIMEDEUVIMED entdecken
Crossref

In-Vitro Evaluation of an Injectable Umbilical Cord-Derived Bioscaffold: A Translational Approach for Repair and Regeneration of Cartilage: Injectable Umbilical Cord-Derived Bioscaffold

Vinod Kumar Verma, Radhika Chowdary Darapuneni, Tirupura Sundari, Syed Sultan Beevi

Regeneration, Reconstruction & Restoration · 28.12.2025

DOI: 10.22037/rrr.v10.49573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Regeneration, Reconstruction & Restoration, erschienen am 28.12.2025. Verfasst von Vinod Kumar Verma und 3 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives: Articular cartilage injuries remain difficult to treat due to the tissue’s limited regenerative capacity and the inconsistent outcomes of current surgical interventions. This study presents a novel injectable bio-scaffold derived from decellularized human umbilical cord extracellular matrix (ECM) enriched with umbilical cord–derived mesenchymal stem cells (UC-MSCs) for cartilage repair. Materials and Methods: Human umbilical cords were decellularized using enzymatic and detergent-based protocols. Decellularization efficacy was confirmed via histological staining, DAPI imaging, DNA quantification. The ECM was processed into an injectable formulation. UC-MSCs were isolated, expanded, and evaluated for scaffold adhesion, proliferation (under varying serum and EGF conditions), and chondrogenic differentiation using Alcian Blue staining at days 1, 6, and 15. Student’s t-test was used for statistical analysis (P-value 90% removal of nuclear content, evidenced by near-complete loss of DAPI-positive nuclei, reduction of DNA concentration from ~14–15 ng/µl in native tissue to ~1 ng/µl in decellularized samples, and markedly faint DNA bands on agarose gel. H&E staining confirmed preservation of ECM architecture with complete cellular clearance. UC-MSCs seeded on the ECM scaffold exhibited enhanced adhesion and significantly increased proliferation compared to cells cultured without scaffolds, reaching > 3 × 106 cells by 72 h. The combination of EGF (10 ng/mL) with 20% FBS yielded the highest proliferation and surface coverage. Chondrogenic differentiation assays demonstrated progressive extracellular matrix accumulation, with Alcian Blue staining showing a substantial increase in glycosaminoglycan (GAG) deposition by day 15, confirming successful scaffold-mediated chondrogenesis. Conclusion: The decellularized human UC-derived injectable scaffold provides a biocompatible microenvironment that promotes UC-MSC proliferation and chondrogenic differentiation. This platform demonstrates strong translational potential for minimally invasive cartilage repair and future clinical application. Future in-vivo studies and clinical translation will establish an advanced regenerative strategy for cartilage repair and osteoarthritis management.

Schlagwörter

human umbilical cord mesenchymal stem cellsdecellularized extracellular matrixcartilage repairchondrogenic differentiationarticular cartilage damageosteoarthritiscell proliferationglycosaminoglycan depositiongrowth factor supplementation

Zitieren

APA

Verma, V. K., Darapuneni, R. C., Sundari, T., & Beevi, S. S. (2025). In-Vitro Evaluation of an Injectable Umbilical Cord-Derived Bioscaffold: A Translational Approach for Repair and Regeneration of Cartilage: Injectable Umbilical Cord-Derived Bioscaffold. Regeneration, Reconstruction & Restoration. https://doi.org/10.22037/rrr.v10.49573

Vancouver

Verma VK, Darapuneni RC, Sundari T, Beevi SS. In-Vitro Evaluation of an Injectable Umbilical Cord-Derived Bioscaffold: A Translational Approach for Repair and Regeneration of Cartilage: Injectable Umbilical Cord-Derived Bioscaffold. Regeneration, Reconstruction & Restoration. 2025. doi:10.22037/rrr.v10.49573

BibTeX
@article{Verma2025,
  author = {Verma, Vinod Kumar and Darapuneni, Radhika Chowdary and Sundari, Tirupura and Beevi, Syed Sultan},
  title = {In-Vitro Evaluation of an Injectable Umbilical Cord-Derived Bioscaffold: A Translational Approach for Repair and Regeneration of Cartilage: Injectable Umbilical Cord-Derived Bioscaffold},
  journal = {Regeneration, Reconstruction & Restoration},
  year = {2025},
  doi = {10.22037/rrr.v10.49573}
}
Kostenlos starten →